Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Guilty by association?

This article was originally published in Scrip

Executive Summary

To very little fanfare of any kind, the International Federation of Pharmaceutical Manufacturers & Associations held its 25th Assembly this week in Washington, DC. In what appears to be a moment of high introspection, even for an introspective organisation like IFPMA, Dr Haruo Naito, CEO of Eisai and the retiring President of IFPMA concluded his remarks at the Assembly by trying to define the organisation's role.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC010762

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel